[pubmed] Current and Upcoming Treatment Modalities in Myasthenia Gravis
Posté : 22 nov. 2021 12:00
J Clin Neuromuscul Dis. 2021 Dec 1;23(2):75-99. doi: 10.1097/CND.0000000000000377.
ABSTRACT
Myasthenia gravis (MG) is one of the extensively studied autoimmune disorder. There has been a dramatic increase in research to further understand molecular pathogenesis of MG and clinical trials for new drugs in MG treatment in the past decade. This review article is to consolidate the available information in simple terms with students, residents, and fellows as target audience for easy learning and help application of this knowledge to clinical practice.
PMID:34808650 | DOI:10.1097/CND.0000000000000377
Source: https://pubmed.ncbi.nlm.nih.gov/3480865 ... 2&v=2.15.0